 High BRCA1 may protect cancer cells by acting in the homologous recombinational repair pathway that removes the damages in DNA introduced by the platinum drugs.The level of "BRCA1" expression is potentially an important tool for tailoring chemotherapy in lung cancer management.Clinical chemotherapeutics can induce enzymatic and non-enzymatic DNA-protein crosslinks.